Supplementary Figure S1. Copy Number Alteration analysis of human prostate cancer confirms loss of PTEN and TP53 genes as a genetic hallmark of metastatic prostate cancer. from MYC Drives &lt;i&gt;Pten/Trp53&lt;/i&gt;-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2